Da EVRA depotplastre indeholder hormoner svarende til dem, der anvendes i kombinations p- piller, er det sandsynligt, at de medfører samme risici.
As the EVRA transdermal patch contains similar hormones to those used in combined birth control pills, it is likely to have the same risks.